Synthesis and Antimicrobial Activity of Silver-Doped Hydroxyapatite Nanoparticles
Table 1
Biofilm active concentrations of the selected compounds on the microbial strains susceptible to the compounds in the qualitative screening assay.
Ag:HAp
Tested parameter
Biofilm active concentration (mg/mL)
Biofilm active concentration (mg/mL)
Biofilm active concentration (mg/mL)
Initial biofilm
Preformed biofilm
Initial biofilm
Preformed biofilm
Initial biofilm
Preformed biofilm
E. coli
0.313
>5
0.313
>5
0.313
>5
K. pneumoniae
1.25
>5
1.25
>5
1.25
>5
E. cloacae
>5
>5
1.25
>5
>5
>5
S. aureus
>5
>5
2.5
>5
0.625
2.5
C. krusei
0.625
2.5
0.313
1.25
0.156
0.156
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
